Respiratory Activities
Identifying Patients at High Risk for Influenza-Related Complications and Treating With Antiviral Therapy: The Role of the Pharmacist
0290-0000-20-006-H01-P
This activity will equip pharmacists with current best practices regarding options for the prevention and treatment of influenza.
1.50
A Managed Care Review of Economic Data and Individualized Treatment Approaches for Moderate to Severe Asthma
0290-0000-19-252-H01-P
This activity will explore the economic data associated with persistent asthma, including costs of exacerbations, hospitalizations, and other downstream costs
1.00
Examining Best Practices for Specialty Pharmacists to Improve the Care of Patients With α1-Antitrypsin Deficiency
0290-0000-19-248-H01-P
This activity will investigate the available therapies for AATD by understanding key characteristics including mechanism of action and efficacy
2.00
Individualizing COPD Treatment to Improve Adherence and Overall Outcomes
0290-0000-19-243-H01-P
This CE activity will focus on current evidence guiding initial and maintenance treatment for patients with COPD as well as the pharmacist’s role in reducing inhaler misuse, improving transitions of care, and preventing exacerbations with appropriate choice of inhaled drugs, smoking cessation counseling, and vaccinations.
2.00